Samsung Biologics
207940.KS
#335
Rank
NZ$97.04 B
Marketcap
$1,310
Share price
-3.95%
Change (1 day)
29.94%
Change (1 year)

EPS for Samsung Biologics (207940.KS)

EPS in 2023 (TTM): $14.47

According to Samsung Biologics 's latest financial reports the company's current EPS (TTM) is $15.97. In 2022 the company made an earnings per share (EPS) of $15.97 an increase over its 2021 EPS that were of $9.06.

EPS history for Samsung Biologics from 2016 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$14.47-9.38%
2022$15.9776.23%
2021$9.0661.48%
2020$5.6121.05%
2019$4.63-12.56%
2018$5.30-330.46%
2017-$2.30-51.86%
2016-$4.78